1. American Cancer Society. Cancer Facts and Figures 2012. Accessed August 24, 2012.

Continue Reading

2. Patil N, Abba M, Allgayer H. Cetuximab and biomarkers in non-small-cell lung carcinoma. Biologics. 2012;6:221-231.   

3. Zhu J, Sharma DB, Gray SW, et al. Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA. 2012;307(15):1593-1601.

4. Laskin J, Crinò L, Felip E, et al. Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390). J Thorac Oncol. 2012;7(1):203-211.

5. Kindler HL, Karrison TG, Gandara DR, et al. Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma. J Clin Onc. 2012;30(20):2509-2515.

6. U.S. National Institutes of Health. Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy. Accessed August 24, 2012.

7. Pirker R, Pereira JR, Szczesna A, et al. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.  Lancet. 2009;373(9674):1525-1531.

8. Pirker R, Pereira JR, von Pawel J, et al. EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol. 2012;13(1):33-42.

9. Kim ES, Neubauer MA, Cohn AL, et al. SELECT: Randomized phase III study of docetaxel (D) or pemetrexed (P) with or without cetuximab (C) in recurrent or progressive non-small cell lung cancer (NSCLC) after platinum-based therapy. Paper presented at the 2012 Annual Meeting of the American Society of Clinical Oncology. Chicago, IL, June 2012. Accessed August 24, 2012.

10. U.S. National Institutes of Health. High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. Accessed August 24, 2012.

11. Grossi F. Management of non-small cell lung in cancer patients with stable disease. Drugs. 2012; 72 Suppl 1:20-27. doi: 10.2165/1163013-S0-000000000-00000.